Ecovision Pharmaceuticals Private Limited
About Ecovision Pharmaceuticals Private Limited
Data last updated:
Ecovision Pharmaceuticals Private Limited is a private limited company based in Patna, Jharkhand, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 19 October 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Ranchi, under CIN U51397JH2005PTC011695.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹9.1 Lakh. It is led by directors Anil Kumar Choudhary (Managing Director) and Satish Chandra Choudhary.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No. 7 Adars Colony East Indra Nagar Road No 1 P O Lohiya Nagar Kankarbagh, Patna, Jharkhand, India.
As per the financials filed for FY 2023, the company reported a revenue of ₹20.19 Lakh, a decline of 26% compared to the previous year. For the same year it recorded a net loss of ₹1.42 Lakh (net margin -7%) and EBITDA of -₹49,034 (EBITDA margin -2.4%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years and 10% over five years.
As per MCA filings, the company has open charges of ₹6 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ecovision Pharmaceuticals Private Limited's registered office is in Patna, Jharkhand. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH No. 7 Adars Colony East Indra Nagar Road No 1 P O Lohiya Nagar Kankarbagh, Patna, Jharkhand, India
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Ecovision Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ecovision Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ecovision Pharmaceuticals Private Limited, buy the company report.
Financials of Ecovision Pharmaceuticals Private Limited
FY 2025 filings availableEcovision Pharmaceuticals Private Limited reported revenue of ₹20.19 Lakh (down 26% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 10% over five years, including a 26% fall in the latest year. EBITDA fell 148% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹49,034 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.42 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -2.4% | ||||
| Net Profit Margin | -7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ecovision Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ecovision Pharmaceuticals Private Limited
Ecovision Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Kumar Choudhary Also directs: Jalalpur City Prabandh Samiti | Managing Director | 19 Oct 2005 | 21 Years 0 Months | Current |
| Satish Chandra Choudhary Also directs: Jalalpur Infrahome Private Limited | Director | 28 Apr 2006 | 20 Years 6 Months | Current |
Peer comparison
Ecovision Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Uniswift Pharmaceuticals Private Limited | ₹20.35 Lakh (FY 2021) | 405.0% | Madiwala, Karnataka, India | |||
| Ecovision Pharmaceuticals Private Limitedthis company | ₹20.19 Lakh (FY 2023) | -₹1.42 Lakh | -7% | -26.0% | Patna, Jharkhand, India | |
| Au Fait Pharmaceuticals Private Limited | ₹20.13 Lakh (FY 2020) | 1531.0% | Gwalior, Madhya Pradesh, India | |||
| Infusion Pharmaceuticals Private Limited | ₹20.05 Lakh (FY 2025) | -65.0% | Ambala, Haryana, India |
To see the full peer comparison of Ecovision Pharmaceuticals Private Limited, buy the company report.
Auditor
Ecovision Pharmaceuticals Private Limited is audited by MUNINDRA NARAIN RAI for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MUNINDRA NARAIN RAI | FY 2017 | 082572 |
Shareholding
The shareholding of Ecovision Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Ecovision Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Jan 2009 | 10142542 | Indian Bank Patna Main Branch | ₹6 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Ecovision Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ecovision Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Ecovision Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Ecovision Pharmaceuticals Private Limited has 3 board changes on record since 2005: 2 appointments and 1 cessation. The latest: Priyanka Kumari ceased to be Director on 25 Jun 2006.
Frequently asked questions
Ecovision Pharmaceuticals is an active private limited company based in Patna, Jharkhand, India. The company works in wholesale, within the trading industry. It was incorporated on 19 October 2005 (21+ years old) and is registered under CIN U51397JH2005PTC011695.
Ecovision Pharmaceuticals has 2 current directors:
- Anil Kumar Choudhary - Managing Director
- Satish Chandra Choudhary - Director
The latest financial statements of Ecovision Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Ecovision Pharmaceuticals is U51397JH2005PTC011695. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ecovision Pharmaceuticals was incorporated on 19 October 2005, making it 21+ years old. It is registered with the Registrar of Companies, Ranchi.
The peers of Ecovision Pharmaceuticals by revenue are Uniswift Pharmaceuticals Private Limited, Au Fait Pharmaceuticals Private Limited, Infusion Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Priyanka Kumari ceased to be Director on 25 Jun 2006. Satish Chandra Choudhary was appointed as Director on 28 Apr 2006. Anil Kumar Choudhary was appointed as Managing Director on 19 Oct 2005.
The registered office of Ecovision Pharmaceuticals is at H No. 7 Adars Colony East Indra Nagar Road No 1 P O Lohiya Nagar Kankarbagh, Patna, Jharkhand, India.
Ecovision Pharmaceuticals operates in the trading industry, in the wholesale segment.
Ecovision Pharmaceuticals has open charges of ₹6 Lakh and no satisfied charges on record as per latest MCA filings.
The compliance status of Ecovision Pharmaceuticals is compliant as of 19 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
